{
    "organizations": [],
    "uuid": "44c4594a6730a475f0dbba39ebb01d97c554eeb5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sarepta-therapeutics-announces-par/brief-sarepta-therapeutics-announces-partnership-with-myonexus-therapeutics-idUSFWN1SA1CL",
    "ord_in_thread": 0,
    "title": "Sarepta Therapeutics Announces Partnership With Myonexus Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Sarepta Therapeutics Inc:\n* SAREPTA THERAPEUTICS ANNOUNCES PARTNERSHIP WITH MYONEXUS THERAPEUTICS FOR THE ADVANCEMENT OF MULTIPLE GENE THERAPY PROGRAMS AIMED AT TREATING DISTINCT FORMS OF LIMB-GIRDLE MUSCULAR DYSTROPHIES\n* SAREPTA THERAPEUTICS INC - SAREPTA IS GRANTED EXCLUSIVE OPTION TO ACQUIRE MYONEXUS\n* SAREPTA THERAPEUTICS INC - A PHASE 1/2A STUDY OF MYO-101 IS SCHEDULED TO BEGIN IN MID-2018\n* SAREPTA THERAPEUTICS INC - COMPANIES PLAN TO REPORT ON 60-DAY BIOPSY DATA IN LATE-2018 OR EARLY 2019\n* SAREPTA - WILL MAKE UPFRONT PAYMENT OF $60 MILLION, ADDITIONAL MILESTONE PAYMENTS TO PURCHASE AN EXCLUSIVE OPTION TO ACQUIRE MYONEXUS\n* SAREPTA - IF ALL DEVELOPMENT-RELATED MILESTONE PAYMENTS ARE MET, CO TO MAKE PAYMENTS OF UP TO $45 MILLION OVER AN ABOUT TWO-YEAR EVALUATION PERIOD Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:25:00.000+03:00",
    "crawled": "2018-05-04T17:04:42.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sarepta",
        "therapeutic",
        "inc",
        "sarepta",
        "therapeutic",
        "announces",
        "partnership",
        "myonexus",
        "therapeutic",
        "advancement",
        "multiple",
        "gene",
        "therapy",
        "program",
        "aimed",
        "treating",
        "distinct",
        "form",
        "muscular",
        "dystrophy",
        "sarepta",
        "therapeutic",
        "inc",
        "sarepta",
        "granted",
        "exclusive",
        "option",
        "acquire",
        "myonexus",
        "sarepta",
        "therapeutic",
        "inc",
        "phase",
        "study",
        "scheduled",
        "begin",
        "sarepta",
        "therapeutic",
        "inc",
        "company",
        "plan",
        "report",
        "biopsy",
        "data",
        "early",
        "sarepta",
        "make",
        "upfront",
        "payment",
        "million",
        "additional",
        "milestone",
        "payment",
        "purchase",
        "exclusive",
        "option",
        "acquire",
        "myonexus",
        "sarepta",
        "milestone",
        "payment",
        "met",
        "co",
        "make",
        "payment",
        "million",
        "evaluation",
        "period",
        "source",
        "text",
        "eikon"
    ]
}